Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norisato Mitsutake

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Thyroid : Official Journal of the American Thyroid Association|March 31, 2006
Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrestDmitry Bulgin, Alexei Podtcheko, Shu Takakura, et al.
Frontiers in Pediatrics|November 21, 2022
Aicardi-Goutières syndrome with <i>SAMHD1</i> deficiency can be diagnosed by unscheduled DNA synthesis testChikako Senju, Yuka Nakazawa, Mayuko Shimada, et al.
Scientific Reports|November 21, 2015
BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from ChernobylNorisato Mitsutake, Toshihiko Fukushima, Michiko Matsuse, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancerKatsu Ishigaki, Hiroyuki Namba, Masahiro Nakashima, et al.
Endocrinology|October 29, 2005
BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesisNorisato Mitsutake, Makoto Miyagishi, Shin Mitsutake, et al.
Endocrine Pathology|October 6, 2007
The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpressionAlexander Abrosimov, Vladimir Saenko, Serik Meirmanov, et al.
Cancer Research|July 5, 2006
Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodelingCleo Mesa, Mana Mirza, Norisato Mitsutake, et al.
Plos One|May 11, 2011
Dedifferentiation of human primary thyrocytes into multilineage progenitor cells without gene introductionKeiji Suzuki, Norisato Mitsutake, Vladimir Saenko, et al.
Endocrinology|July 26, 2008
Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cellsZhaowei Meng, Norisato Mitsutake, Masahiro Nakashima, et al.
Oncology Reports|June 21, 2006
Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiationAtsushi Kumagai, Hiroyuki Namba, Norisato Mitsutake, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Thyroid : Official Journal of the American Thyroid Association|March 31, 2006
Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrestDmitry Bulgin, Alexei Podtcheko, Shu Takakura, et al.
Frontiers in Pediatrics|November 21, 2022
Aicardi-Goutières syndrome with <i>SAMHD1</i> deficiency can be diagnosed by unscheduled DNA synthesis testChikako Senju, Yuka Nakazawa, Mayuko Shimada, et al.
Scientific Reports|November 21, 2015
BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from ChernobylNorisato Mitsutake, Toshihiko Fukushima, Michiko Matsuse, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancerKatsu Ishigaki, Hiroyuki Namba, Masahiro Nakashima, et al.
Endocrinology|October 29, 2005
BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesisNorisato Mitsutake, Makoto Miyagishi, Shin Mitsutake, et al.
Endocrine Pathology|October 6, 2007
The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpressionAlexander Abrosimov, Vladimir Saenko, Serik Meirmanov, et al.
Cancer Research|July 5, 2006
Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodelingCleo Mesa, Mana Mirza, Norisato Mitsutake, et al.
Plos One|May 11, 2011
Dedifferentiation of human primary thyrocytes into multilineage progenitor cells without gene introductionKeiji Suzuki, Norisato Mitsutake, Vladimir Saenko, et al.
Endocrinology|July 26, 2008
Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cellsZhaowei Meng, Norisato Mitsutake, Masahiro Nakashima, et al.
Oncology Reports|June 21, 2006
Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiationAtsushi Kumagai, Hiroyuki Namba, Norisato Mitsutake, et al.
Pageof 11